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One hundred pediatric and young adult patients under-
went implantation of an atrial tracking pacemaker. Sev-
enty-four pacemakers paced in an atrioventricular (AV)
sequential mode at the lower rate limit (DOD) while 26
paced in a ventricular demand mode at the lower rate
limit (VDD). Five patients required reoperation during
follow-up of 1 month to 2.5 years (mean 1.5 years). Six
additional patients required programming to ventricular
demand (3) or AV sequential (3) pacing , because of de-
velopment of sinus bradycardia (2), atrial sensing prob-
lems (1) or pacemaker-mediated tach ycardia (3). Pulse
Pediatric and young adult patients should benefit more than
other groups from the use of atrial tracking pacemakers .
They are believed to have , in many instances. a nearly
normal myocardium and a nearly normal sinu s node re-
sponse to exercise . Even patients with sinus bradycardia at
rest have significant increases in sinus rate with exercise .
The patient's activity level also seems to dictate the use of
an atrial tracking device. Despite the theoretical advantages
of the use of atrial tracking pacemakers in children, several
potential technical drawbacks have prevented their use in
large numbers of pediatric patients ( 1- 5). These have in-
cluded the size of pulse generators , size of the trans venous
lead s and probl em s with atr ial threshold s and sensing using
epi cardi al leads.
It was the purpose of this study to determine if the recent
improvements in pulse generator and lead technology make
atr ial tracking pacing feasible in pediatric and young adult
patients . We have used the term " atrial trackin g" to indicate
a pacem aker that senses atrial acti vity and pace s the ventricle
at a fixed time period later. At the lower rate limit, these
devices can either pace the ventricle alone (VOO) or pace
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generators that could sense atrial signals < 1.0 mV and
had a programmable atrial refractory period did not
require reprogramming out of the atrial tracking mode.
No patient developed atrial flutter or fibrillation.
Sensing problems during exercise occurred in 37%
of the first 60 pacemakers but in none of the last 40,
which had improved electronic components. Atrial
tracking pacing is feasible in pediatric and young adult
patients.
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both the atrium and the ventricle (ODD), Each currently
ava ilable model also senses ventricular acti vity,
Methods
Patients. In September 1981 , a new atrial tracking , ven-
tricular-inhibited (VOO) pacem aker became available which
we believed was small enough to be implanted transvenously
in most pediatric patients. At approximately the same time,
polyurethene. tined atrial and ventricular leads and screw-
in leads also became available . In July 1981. we had begun
to implant most pacemakers in pedi atr ic patients in the car-
diac ca theterization laboratory using the transvenous ap-
proach. Beginning in September 1981 . we evaluated each
pediatric and young adult patient who had indications for a
pacemaker for the use of atrial tracking pacemakers. We
tested the postulate that physiologic pacemakers would be
feas ible in children.
The criterion/or use alan atrial tracking pacemaker Ivas
a contraindication to atrial demand pacing. This was either
I ) seco nd or third degree atrioventricular (AV) block. 2)
development of seco nd degree block at an atrial pacin g rate
less than 110 beats/min, or 3) previous repair of a congenita l
heart defect including a ventricular septal defect. A patient
who had had parox symal atri al flutter and was under ex-
cellent medical control was not considered to have a con -
traindication to use of an atri al tracking pacemaker.
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Implantation technique. It was believed that transven-
ous implantation would result in better atrial sensing and
pacing. Therefore, each patient was initially considered for
transvenous implantation. Contraindications to transvenous
implantation were: I) weight less than 13 kg, 2) right to
left shunt, or 3) prosthetic tricuspid valve or tricuspid atre-
sia. Patients who had one of these contraindications were
referred for surgical implantation of epicardial pacemaker
leads and were included in this series (6). The techniques
of transvenous implantation have been previously described
(7,8). Patients who had not undergone previous open heart
surgery had implantation of a J-shaped, tined atrial lead and
a tined ventricular lead. Patients who had had previous open
heart surgery, a very dilated right atrium or right ventricle
received screw-in leads. Transvenous implantation was by
the subclavian introducer technique using a retained wire
for the second introducer. Epicardial implantation was by
the subxiphoid approach, or at the time of open heart sur-
gery, using standard two turn screw-in ventricular leads and
Medtronic 4951 atrial leads (I).
Figure 1. A, Upper rate limit (URL) response of an automatic
(DOD) pacemaker with the upper rate limit set at 175 beats/min.
The upper rate limit timer will not allow two ventricular spikes to
be closer together than 343 ms. To avoid this, it increases the
atrioventricular (AV) interval, which effectively shortens the ven-
triculoatrial interval. When the atrial electrogram thus falls within
the atrial refractory (nonsensing) period (ARP), set to 155 ms in
this case, the ventricular response is omitted and the cycle starts
over. The response is very similar to a Wenckebach response. If
the sum of the atrial refractory period and the AV interval is greater
than the upper rate limit cycle length, then 2: I block will occur,
as in this case. B, Diagrammatic representation of a pacemaker
timing during upper rate limit behavior. The atrial sensing channel
is represented on top, the atrial refractory period beginning with
ventricular stimulation is diagrammed by squares and the ven-
tricular pace events by downward marks. It can be seen that for
this partial diagram of the main part of Figure I beginning with
the dotted line, which is intended to represent an unsensed atrial
event. the unsensed event is just inside the atrial refractory period.
The next atrial event is sensed with a normal AV interval and the
AV interval gradually increases; the upper rate limit timer will not
let two ventricular events get closer because that would result in
a rate of 175/min. Finally, the sixth atrial event is again within
the atrial refractory period and does not result in a ventricular pace
event, thereby maintaining the ventricular rate at approximately
175 beats/min. The behavior mimics Wenckebach-type second
degree AV block.
Follow-up. Patients were followed up in the usual man-
ner with several surface electrocardiograms and at least one
ambulatory electrocardiogram before discharge. At 6 weeks'
evaluation, a treadmill exercise test was performed on each
patient whose age and clinical condition were suitable. Each
patient was followed monthly for the first year by trans-
telephonic electrocardiogram and every 3 months thereafter.
Each patient had yearly "hands on" outpatient evaluation
including a chest radiograph.
Electrophysiologic evaluation. Each patient had pre-
operative electrophysiologic evaluation. From September
1981 to September 1983, this consisted of a formal elec-
trophysiologic study using multiple catheters. After Sep-
tember 1983, patients who did not have known or suspected
tachyarrhythmias were evaluated at the time of pacemaker
implantation using the permanent pacing leads. The atrial
pacing rate at which second degree AV block developed
was evaluated. Retrograde conduction was evaluated by
pacing the ventricle and recording an atrial electrogram.
The retrograde conduction interval, if present, was mea-
sured by this technique.
Programmed settings. In order to obtain the maximal
benefit from atrial tracking pacing, every effort was made
to set the pacing parameters to allow the largest fluctuation
of pacing rates. An upper rate limit of 175 or 180 beats/min
was used if possible (Fig. I). AV intervals were set at 100
to 150 ms to allow the high upper rate limits to be used.
Atrial refractory periods, when programmable, were set at
the lowest values, that is, 155 ms if the patient did not have
retrograde conduction. If the patient did have retrograde
conduction, the atrial refractory period was set just longer
than the longest VA interval found during premature stim-
ulation. In the early units without atrial pacing capabilities,
low lower rate limits were used, usually 50 beats/min to
maintain AV synchrony as much as possible. When atrial
synchronous units with atrial pacing (DOD) became avail-
able, we began to use higher lower rate limits in the 60 to
80 range depending on age.
On ambulatory electrocardiography and treadmill test-
ing, a careful evaluation was made for several potential
problems of atrial synchronous pacing. Pacemaker-mediated
tachycardia, atrial undersensing, atrial oversensing and sen-
sing of the atrial spike by the ventricular sensing circuit
resulting in ventricular inhibition were searched for using
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Figure 2. Ante roposter ior supine chest radiograph of a 3 day old
baby with a part ial endoca rdia l cushion defect and complete atrio-
ventricular (A Vj block who had implantation of a DDD pacemaker
by subxiphoid technique at I day of age. The leads were implanted
on the right ventricle and right atrium, and the pulse generat or
was placed in the rectus sheath . A central venous line, nasoga stric
tube and electrocardiographic monitoring wires are also presen t.
electrocardiography, treadmill exercise electrocardiography
and 24 hour ambulatory electrocardiography.
Results
Clinical and pacemaker features, From September 1981
to February 1985 , 100 pediatric and young adult patients
had implantation of an atrial tracking pacemaker. Their ages
ranged from I day to 33 years (mean 11.7 years) (Fig. 2).
The anatomic diagnosis of these patients included an oth-
erwise normal heart (40 patients), congenital heart disease
(8 patients), postoperative surgical repairof congenital heart
disease (27 patients) and other acquired heart disease (25
patients). The electrophysiologic diagnosis of these patients
included third degree AY block (53 patients), sick sinus
syndrome (26 patients), supraventricular tachyarrhythmias
suppressed by antiarrhythmic drugs (12 patients) and other
diagnoses (9 patients).
The pulse generators used in this group of pati ents in-
cluded 26 Medtronic model 7100 YDD pacemakers, 20
Medtronic model 7000 DOD pulse generators and 19 Med-
tronic 7000-A1235 pulse generators that had a 235 ms atrial
refractory period instead of the 155 ms refractory period in
the 7100 and 7000 models. The 7000-A pulse generators
also had a post-premature ventricular complex extension of
the atrial refractory period to 340 ms. One Pacesetter model
281 DOD pulse generator was used. Twenty-four second
generation DOD pacemakers with a programmable atrial
refractory period, enhanced atrial sensitivity and bidirec-
tional telemetry were used; these were Medtronic 7005,
7006 and Intermedic 283.01 models.
In the total group, 68 pacemakers were implanted by
transvenous technique and 32 by epicardial technique. Fol-
lOW-Up of this group of pulse generators ranged from I
month to 2112 years (average 1.7 years).
Acute atrial pacing thresholds averaged 1.1 Y at 0.5 ms
pulse width. The average acute atrial depolarization re-
corded from the implanted lead was 2.3 mY.
Follow-up. Of the initial group of 26 patients with a
YDD pulse generator, 23 had a pacemaker that was in the
Figure 3. A, Lead I electrocardiogram of a patient with a first
generation DDD pacemaker with a short nonprogramm able atrial
refract ory period with the upper rate limit set at 125 beats/m in and
the AV interva l set at 250 ms. The first five beats are atrial paced
with the patient's inherent ventricular conduction occurring at less
than 250 ms, thus inhibiting the ventricular output. The sixth beat
is a premature ventricular complex with a probable retrograde P
wave following it. Under these condi tions. this pulse generator
responded with a ventri cular beat at a cycle length of 600 ms,
which resulted in retrograde conduction and pacemaker-mediated
tachycardia. D, Diagrammatic representation of the timing events
of the DDD elec trocardiog ram. Thi s diagram begins with the third
beat in A. For the first two eve nts atrial pacing (P ) occurs. The
patient' s intrinsic AV conduction conducts the impulses and ven-
tricle sensing (S) occ urs. The third event is a premature ventricular
beat that is sensed by the ventricular channel but may not besensed
by the atrial channel because the P wave may fall within the atrial
refractory period. Because of the ecce ntric behavior of this par-
ticular pulse generator , the next eve nt is a ventricular paced eve nt,
afte r which the P wave is sensed and a run of a pacemaker-med iated
tachycardia is begun using the patient's intrinsic retrograde con-
duction.
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VDD mode at last follow-up and 3 had had their pacemaker
reprogrammed to the VVI mode. This reprogramming was
necessary in two patients because of the development of
sinus bradycardia after implantation, althoughboth had been
screened by noninvasive and invasive electrophysiologic
study for sick sinus syndrome. Both patients had epicardial
implantation of their pulse generator, and it is speculated
that pericarditis after the epicardial implantation may have
led to the development of sick sinus syndrome. The devel-
opment of sick sinus syndrome in these two patients led to
competition between the atrial sensing and the ventricular
demand modes. The third patient's pacemaker was repro-
grammed because atrial sensing could not be maintained.
This pulse generator had a maximal sensitivity of 1.25 mV
on the atrial channel; endocardial leads had been used.
Of the 74 DDD pulse generators implanted, 71 were still
in DOD mode at the most recent follow-up. Three had been
reprogrammed permanently to DVI (AV sequential) mode;
in each case, this was done because of pacemaker-mediated
tachycardia in a patient with retrograde conduction (Fig. 3).
One of the units reprogrammed was one of the original 7000
models while two were 7000-A models. Of the 34 pulse
generators with a programmable atrial refractory period(that
is, models 7005, 7006 and 283-01), none had to be repro-
grammed to AV sequential mode. One patient in this group
developed pacemaker-mediated tachycardia unexpectedly 6
weeks after implantation. Testing by ventricular pacing in
this patient had revealed no retrograde conduction either at
electrophysiologic study or later at implantation of the pulse
generator, but it was evident on retesting at the time of
pacemaker-mediated tachycardia. The retrograde interval
was estimated using the sense and pace event markers. The
atrial refractory period was extended to encompass this in-
terval and no further pacemaker-mediated tachycardia oc-
curred. This is the only patient in the series who did not
have retrograde conduction at implantation who developed
it in follow-up.
Exercise testing. Exercise testing was carried out in 31
of the 90 patients in this group. Two patients developed
atrial undersensing at peak exercise which could not be
controlled by programming the pulse generators to maximal
sensitivity. The maximal sensitivity in each of these was
1.25 mY. Seven of the 24 pulse generators reverted to the
noise rate at peak exercise. This occurred only in model
7000 and model 7000-A. Asynchronous pacing did not re-
sult in ventricular arrhythmias.
One patient had accelerated junctional escape rhythm
early during exercise testing and the pacemaker failed to
sense these ventricular events, apparently because the ven-
tricular electrogram fell within the blanking period. No ep-
isodes of inhibition of ventricular stimulation due to sensing
the atrial pacemaker spike (cross talk) were noted during
exercise.
Ambulatory electrocardiographic monitoring. One to
four 24 hour ambulatory electrocardiograms were recorded
from each patient and the tapes were scanned manually by
superimposition. Noise rate reversion was not detected in
any patient during ambulatory monitoring. Transient atrial
undersensing was noted in five patients but did not lead to
clinical problems. Cross talk was not observed. One patient,
different from the one detected during exercise testing, was
noted to have ventricular undersensing, apparently because
the ventricular electrogram was lost in the blanking period.
Pulse generator failure. Two pulse generators failed
during follow-up, one at 3 months and one at 4 months after
implantation. Both pulse generators were clinical evaluation
models. One 18 year old patient, who had a syncopal spell
when the pulse generator failed, was extremely weak until
it was replaced; she had hada ventriculardemandpacemaker
before the VDD unit was implanted. When asked, she said
she wouldaccept anotherclinical evaluation unit of the same
type, because she felt so much better and had a better ex-
ercise tolerance with the atrial tracking pacemaker. The
other patient also underwent reimplantation with the same
model as the one that failed.
Lead problems. Three patients required reoperation for
pacing lead problems. One had fracture of a ventricular lead
during an accident. One patient developed atrial and ven-
tricular undcrsensing 2 months after implantation and re-
quired repositioning of the pacemaker leads. The final pa-
tient developedatrial undersensing twice and eventually had
epicardial lead implantation. Each of these patients had early
units with 1.25 mV maximal atrial sensitivity.
Discussion
This study shows that atrial tracking pacing is feasible
in pediatric and young adult patients. We did not scientif-
ically evaluate the hemodynamic usefulness of atrial track-
ing pacemakers. The patients' subjective responses to these
pacemakers were excellent. Many of the patients had pre-
viously had a ventricular demand pacemaker, and they fre-
quently spontaneously stated that they feIt much better and
had better exercise tolerance with the new pacemaker.
Pacing leads. Lead-related problems were uncommon
in this series. None of our patients developed a problem
related to the polyurethane insulation. One patient had frac-
ture of a ventricular lead during a major physical trauma.
The insulation was intact, but the conductor was completely
severed. This lead could not be removed and was replaced
with another tined lead. It is anticipated that, as they grow,
some patients will require advancement of the leads. We
are currently monitoring this by observing their chest ra-
diographs for straightening of the leads. No difference was
observed in this short follow-up between the performance
JACC Vol. 9, No.4
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of epicardial and endocardial leads. Each was so good that
differences could not be determined.
Retrograde AV conduction. Problemswith pacemaker-
mediated tachycardia were relatively infrequent in this pe-
diatric and young adult group. Retrograde conduction was
relatively uncommon in these patients (9). It was not found
in any patient with congenital or surgical complete AV
block, although it frequently occurred in patients with sick
sinus syndrome. The use of pulse generators with a pro-
grammable atrial refractory period appears to have essen-
tially solved this problem, The use of a longer atria! re-
fractory period, however, compromises the upper rate limit
of the pacemaker unless very short AV intervals are used.
No erosion occurred during follow-up in this series of
patients. In very thin, small patients, however, the subcu-
taneous pocket was not esthetic. We, therefore, began to
use a subpectoral pocket, which is much more esthetic and
will probably prevent erosion. We did this only with the
bipolar units because of the potential problems of muscle
stimulation if a unipolar unit is positioned under the pec-
toralis muscle. We did not encounter problems with pro-
gramming subpectoral pacemakers.
Oversensing during exercise. Significant problems oc-
curred using unipolar 7000 and 7000-A pulse generators at
peak exercise (10). Many of these units reverted to noise
mode, apparently because of pectoral muscle oversensing.
Model 7100, 7005 and 283-0I pulse generators seemed
much less sensitive to this problem. The bipolar 7006 has
not yet demonstrated noise rate reversion during peak ex-
ercise.
Conclusions. Atrial tracking pacing is feasible in pe-
diatric and youngadult patients.Technically, improvements
in the pulse generators have resulted in fewer and fewer
problems. Subpectoral implantation will improve the cos-
metic result for transvenous implants. Although it has been
showndefinitively for adults that atrial tracking pacemakers
result in an improved cardiac output, we believe it is stili
necessary to confirm this in a pediatric population using
measurements of cardiacoutputduringexercise testing(II).
Until this study is accomplished, we consider that the sub-
jective improvement described by the patients warrants the
use of these pacemakers in pediatric and young adult pa-
tients.
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